Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

691 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.
Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, Ramadori G, Bodenheimer H Jr, Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM; PEGASYS International Study Group. Hadziyannis SJ, et al. Among authors: rizzetto m. Ann Intern Med. 2004 Mar 2;140(5):346-55. doi: 10.7326/0003-4819-140-5-200403020-00010. Ann Intern Med. 2004. PMID: 14996676 Clinical Trial.
Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?
Pellicano R, Puglisi G, Ciancio A, Balzola F, Saracco G, Ciccone G, Baldi I, Abate ML, Smedile A, Rizzetto M. Pellicano R, et al. Among authors: rizzetto m. J Med Virol. 2008 Apr;80(4):628-31. doi: 10.1002/jmv.21123. J Med Virol. 2008. PMID: 18297716
[No authors listed] [No authors listed] PMID: 31153438
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta.
Niro GA, Ciancio A, Gaeta GB, Smedile A, Marrone A, Olivero A, Stanzione M, David E, Brancaccio G, Fontana R, Perri F, Andriulli A, Rizzetto M. Niro GA, et al. Among authors: rizzetto m. Hepatology. 2006 Sep;44(3):713-20. doi: 10.1002/hep.21296. Hepatology. 2006. PMID: 16941685 Clinical Trial.
Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas.
Andriulli A, Stroffolini T, Mariano A, Valvano MR, Grattagliano I, Ippolito AM, Grossi A, Brancaccio G, Coco C, Russello M, Smedile A, Petrini E, Martini S, Gaeta GB, Rizzetto M. Andriulli A, et al. Among authors: rizzetto m. Eur J Intern Med. 2018 Jul;53:79-84. doi: 10.1016/j.ejim.2018.02.015. Epub 2018 Feb 21. Eur J Intern Med. 2018. PMID: 29475770
Prospective randomized trial: endoscopic follow up 3 vs 6 months after esophageal variceal eradication by band ligation in cirrhosis.
Debernardi Venon W, Elia C, Stradella D, Bruno M, Fadda M, DeAngelis C, Rizzetto M, Saracco G, Marzano A. Debernardi Venon W, et al. Among authors: rizzetto m. Eur J Intern Med. 2014 Sep;25(7):674-9. doi: 10.1016/j.ejim.2014.06.013. Epub 2014 Jul 10. Eur J Intern Med. 2014. PMID: 25018142 Clinical Trial.
Interferon beta-1a alone or in combination with ribavirin: a randomized trial to compare efficacy and safety in chronic hepatitis C.
Pellicano R, Craxi A, Almasio PL, Valenza M, Venezia G, Alberti A, Boccato S, Demelia L, Sorbello O, Picciotto A, Torre F, Ideo G, Cattaneo C, Berrutti M, Rizzetto M. Pellicano R, et al. Among authors: rizzetto m. World J Gastroenterol. 2005 Aug 7;11(29):4484-9. doi: 10.3748/wjg.v11.i29.4484. World J Gastroenterol. 2005. PMID: 16052676 Free PMC article. Clinical Trial.
Re-treatment with interferon-beta of patients with chronic hepatitis C virus infection.
Pellicano R, Palmas F, Cariti G, Tappero G, Boero M, Tabone M, Suriani R, Pontisso P, Pitaro M, Rizzetto M. Pellicano R, et al. Among authors: rizzetto m. Eur J Gastroenterol Hepatol. 2002 Dec;14(12):1377-82. doi: 10.1097/00042737-200212000-00015. Eur J Gastroenterol Hepatol. 2002. PMID: 12468961
Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin.
Lavezzo B, Franchello A, Smedile A, David E, Barbui A, Torrani M, Ottobrelli A, Zamboni F, Fadda M, Bobbio A, Salizzoni M, Rizzetto M. Lavezzo B, et al. Among authors: rizzetto m. J Hepatol. 2002 Aug;37(2):247-52. doi: 10.1016/s0168-8278(02)00109-5. J Hepatol. 2002. PMID: 12127430 Clinical Trial.
691 results
Jump to page
Feedback